Rufloxacin enhances susceptibility of Escherichia coli to leukocyte activity.
Herrera
I
I
Department of Microbiology, Faculty of Medicine, Complutense University of Madrid, Spain.
Martinez
P
P
Perez
P
P
Martin
M
M
Gomez-Lus
M L
ML
Prieto
J
J
D000890:Anti-Infective Agents / Q000494:pharmacology*; D001770:Blood Bactericidal Activity / Q000187:drug effects*; D004926:Escherichia coli / Q000187:drug effects* / Q000276:immunology; D024841:Fluoroquinolones; D006801:Humans; D015378:Imipenem / Q000494:pharmacology; D015363:Quinolones / Q000494:pharmacology*
D000890:Anti-Infective Agents; D024841:Fluoroquinolones; D015363:Quinolones; D015378:Imipenem; C060328:rufloxacin